What is Zenapax?

Daclizumab (trade name Zenapax) is a therapeutic humanized monoclonal antibody. It is used to prevent rejection in organ transplantation, especially in kidney transplants. The drug is also under investigation for the treatment of multiple sclerosis.

Daclizumab works by binding to CD25, the alpha subunit of the IL-2 receptor of T cells. The drug is marketed in the US, but not in Europe.

Questions and answers on "Zenapax"

I just had a laparscopic hysterectomy for endometrial cancer. i was told that it was Stage1 . The pathology report after surgery
said it was...

doctor1 MD

Brief Answer:
Need at least some additional treatment

Detailed Answer:
Thanks for your query.

To answer your queries one by one..
1. why didn't...

Read Full Thread   Ask a Doctor Now

Recent questions on Zenapax

Ask Question
Doctor Image

Hi, I am Dr. Andrew Rynne (Family Physician). I will be guiding you through the process. Please write your question below.

Related Drugs/Medications
Related Treatment/Therapy